FLGT (Fulgent Genetics) Float Percentage Of Total Shares Outstanding: 63.46% (As of Jul. 04, 2026)


FLGT Fulgent Genetics Inc FLGT
64 GF Score
Price $20.86
GF Value $24.05
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Fulgent Genetics Float Percentage Of Total Shares Outstanding?

Fulgent Genetics FLGT +0.14% 64 Float Percentage Of Total Shares Outstanding is 63.46% as of Jul. 04, 2026. GuruFocus rates FLGT with a GF Score™ of 64/100 and a GF Value™ of $24.05 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Fulgent Genetics's float shares is 18.02 Mil. Fulgent Genetics's total shares outstanding is 28.40 Mil. Fulgent Genetics's float percentage of total shares outstanding is 63.46%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Fulgent Genetics's Insider Ownership is 9.61%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Fulgent Genetics's Institutional Ownership is 66.41%.

FLGT
64GF Score
Fulgent Genetics Inc FLGT
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fulgent Genetics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Fulgent Genetics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=18.02/28.40
=63.46%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 63.46% mean?
Fulgent Genetics (FLGT) has a Float Percentage Of Total Shares Outstanding of 63.46% as of Jul. 04, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Fulgent Genetics and its competitors.
Is Fulgent Genetics' Float Percentage Of Total Shares Outstanding too high?
Fulgent Genetics' current Float Percentage Of Total Shares Outstanding is 63.46%. Overall, Fulgent Genetics has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fulgent Genetics' Float Percentage Of Total Shares Outstanding compare to MYGN and CSTL?
Fulgent Genetics' Float Percentage Of Total Shares Outstanding of 63.46% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Diagnostics & Research company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Diagnostics & Research industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Fulgent Genetics and its competitors. Fulgent Genetics's current Float Percentage Of Total Shares Outstanding is 63.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fulgent Genetics stock overvalued right now?
Based on GuruFocus' analysis, Fulgent Genetics (FLGT) is currently considered Modestly Undervalued. The stock's GF Value™ is $24.05, compared to a current price of $20.86 — trading 13.3% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 63.46%. Fulgent Genetics' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Fulgent Genetics (FLGT), the current Float Percentage Of Total Shares Outstanding is 63.46% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fulgent Genetics (FLGT) Overvalued in 2026?

Based on GuruFocus' analysis, Fulgent Genetics stock appears to be undervalued. The current stock price of $20.86 is trading 13.3% below its estimated GF Value™ of $24.05. GuruFocus considers Fulgent Genetics to be Modestly Undervalued.

Key valuation signals for FLGT:

  • Float Percentage Of Total Shares Outstanding: 63.46%
  • GF Value™: $24.05 vs. price of $20.86 (13.3% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the FLGT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fulgent Genetics Business Description

Other Exchanges FLGT:Mexico
Address 4399 Santa Anita Avenue, El Monte, CA, USA, 91731
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
64GF Score

Get the complete analysis for FLGT

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.86
Price
$24.05
GF Value